ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,450Medicare Part D Prescriptions Filled, Including Refills

Rank: 91 out of 355

$418K Total Retail Price of All Prescriptions

Rank: 102 out of 355

479 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Rhode Island
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $47 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
ATORVASTATIN CALCIUM 542 517 83 1 4
AMLODIPINE BESYLATE 406 393 63 2 2
LEVOTHYROXINE SODIUM 359 344 48 3 6
SIMVASTATIN 350 309 52 4 3
LISINOPRIL 319 304 51 5 1
OMEPRAZOLE 309 286 51 6 5
FUROSEMIDE 221 207 41 7 7
ALLOPURINOL 203 198* 24 8 29
HYDROCODONE-ACETAMINOPHEN 189 135 43 S3 9 17
METOPROLOL TARTRATE 187 157 28 10 8
ZOLPIDEM TARTRATE 173 168* 35 11 28
CITALOPRAM HBR 158 153* 22 12 18
GABAPENTIN 146 130 23 13 19
ALPRAZOLAM 139 134* 34 B 14 21
CRESTOR 134 129* 24 15 34
LOSARTAN POTASSIUM 131 131 18 16 13
WARFARIN SODIUM 126 126 23 17 10
METFORMIN HCL 126 121* 18 17 12
HYDROCHLOROTHIAZIDE 114 101 20 19 9
PREDNISONE 97 92* 39 20 41
ALENDRONATE SODIUM 96 91* 16 21 23
SYNTHROID 96 91* 13 21 43
METFORMIN HCL ER 95 83 13 23 53
BISOPROLOL FUMARATE 91 86* 12 24 71
GLIPIZIDE 91 91 15 24 47
ESCITALOPRAM OXALATE 90 90 13 26 51
LORAZEPAM 87 82* 21 B 27 30
BENICAR 86 86 17 28 111
ADVAIR DISKUS 79 <11 <11 29 45
SERTRALINE HCL 79 79 13 29 15
DONEPEZIL HCL 77 77 11 31 24
TRAZODONE HCL 74 74 20 32 16
GLIMEPIRIDE 73 73 13 33 50
ATENOLOL 73 73 11 33 11
METOPROLOL SUCCINATE 67 67 13 35 20
CLONAZEPAM 65 60* 12 B 36 39
TAMSULOSIN HCL 65 60* 18 36 26
MONTELUKAST SODIUM 62 <11 <11 38 56
MELOXICAM 59 54* 13 39 54
POTASSIUM CHLORIDE 56 <11 <11 40 61
TEMAZEPAM 53 53 15 B 41 112
TRIAMTERENE-HCTZ 53 <11 <11 41 46
PRAVASTATIN SODIUM 52 <11 <11 43 14
BISOPROLOL-HYDROCHLOROTHIAZIDE 50 <11 <11 44 91
CLOPIDOGREL 50 <11 <11 44 22
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.